E

EMED Technologies

Subcutaneous infusion systems for home care

Operations Manager

Full-TimeUpdated on 10/24/2026
No salary listed
Mid
Bachelor's
New York, NY, USA
In Person
Operations & LogisticsSupply Chain Management

About the job

Requirements
  • A bachelor's degree in Operations Management, Supply Chain Management, Business Administration, Engineering, or a related field is required.
  • At least 3 years of experience in operations, supply chain, or manufacturing management is required; experience in the medical device or life sciences industry is preferred.
  • Working knowledge of FDA 21 CFR Part 820/QMSR, ISO 13485, and EU MDR operational requirements is required; experience in a regulated manufacturing environment is strongly preferred.
  • Demonstrated experience managing contract manufacturers and third-party suppliers across multiple geographies is required.
  • Proficiency with ERP, invoicing, and supply chain management systems is required, as are strong Microsoft Excel skills.
  • The role requires organizational ability and a track record of managing multiple concurrent priorities in a fast-paced, lean-team environment.
  • Strong analytical and problem-solving skills, including the ability to synthesize operational data into actionable recommendations for leadership, are required.
  • Excellent written and verbal communication skills and comfort interfacing with internal teams, external partners, and senior leadership are required.
  • The role requires the ability to work independently, exercise sound judgment under ambiguity, and drive issues to resolution with minimal supervision.
Responsibilities
  • Oversee and coordinate day-to-day operational functions, including supply chain execution, contract manufacturing oversight, logistics, and cross-functional process improvement.
  • Coordinate across manufacturing, quality, regulatory, finance, and commercial teams to maintain operational continuity and scalability across U.S. and international markets.
  • Manage operational workflows across supply chain, manufacturing coordination, distribution logistics, and customer fulfillment to ensure product availability and on-time delivery.
  • Act as the primary operational liaison with contract manufacturers and third-party logistics partners, monitoring performance against quality standards, lead times, and contractual obligations.
  • Coordinate with Mexico manufacturing operations on production schedules, capacity planning, and compliance with applicable standards, including NOM-241 and ISO 13485.
  • Administer and optimize ERP, invoicing, and operational management platforms to maintain accurate inventory data, procurement records, and reporting; lead continuous improvement initiatives to improve system utilization.
  • Develop and present operational key performance indicators to leadership regularly, providing visibility into supply chain health, production performance, and fulfillment metrics.
  • Coordinate with Quality and Regulatory Affairs on nonconformance investigations, corrective and preventive action execution, supplier qualifications, and audit readiness from an operational standpoint.
  • Partner with Finance to reconcile procurement and logistics costs, track operational spending against budget, and contribute to annual planning.
  • Support Sales and Marketing with order management, fulfillment execution, and customer-facing operational processes to meet commercial commitments.
  • Lead or support new product introduction activities from an operations perspective, including component sourcing, supplier onboarding, and production readiness reviews.
  • Identify and implement process improvements across operations using lean principles to reduce waste, shorten lead times, and improve cross-functional efficiency.
  • Support international distribution across the EU, Japan, and other markets by coordinating order management, documentation, and regulatory shipment requirements.
Desired Qualifications
  • Experience in the medical device or life sciences industry is preferred.
  • Experience in a regulated manufacturing environment is strongly preferred.

About the company

EMED Technologies manufactures medical devices and drug delivery systems specifically for subcutaneous infusion of biologics and specialty drugs. Its products, such as the SCIg60 system and VersaPump, use mechanical syringe pumps and variable flow rate controllers to allow patients to safely administer medication at home. Unlike many competitors, the company provides a complete end-to-end B2B solution that includes device design, AI-monitored manufacturing, and final packaging for pharmaceutical partners. The company's goal is to increase patient independence and quality of care by providing accessible, home-based infusion platforms across global markets.

Company Size

11-50

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$8M

Headquarters

California

Founded

1987

Get referred to EMED Technologies

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • EMED subsidiary closed an $8 million equity financing on February 24, 2026.
  • EMED updated its website on October 5, 2026, signaling active commercialization.
  • EMED added a Scientific Advisory Board and expanded VersaRate IP in 2025.

What critics are saying

  • EMED's patent war with Repro-Med Systems remains open and expensive.
  • Federal Circuit precedent already invalidated most of EMED's needle-shield claims in 2020.
  • A VersaRate or needle-patent setback would erase EMED's moat and partner leverage.

What makes EMED Technologies unique

  • EMED holds 15 patents across needle safety, insertion, and variable flow control.
  • VersaRate gained U.S. Patent No. 12,403,243 on September 3, 2025.
  • EMED supplies end-to-end subcutaneous infusion devices, assembly, labeling, and packaging worldwide.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Professional Development Budget

Growth & Insights and Company News

6 month growth

4%

1 year growth

4%

2 year growth

4%
PR Newswire
Feb 24th, 2026
EMED Subsidiary Closes $8 Million Equity Financing

/PRNewswire/ -- Today, EMED Technologies, a global leader in drug delivery and innovative infusion therapy devices announced that its subsidiary closed a...

PR Newswire
Sep 30th, 2025
eMed Population Health Appoints Dr. Dyan Hes as Chief Medical Officer

MIAMI, Sept. 30, 2025 /PRNewswire/ - eMed Population Health, Inc. today announced the appointment of Dr. Dyan Hes as Chief Medical Officer.

Morningstar
Sep 8th, 2025
eMed Population Health Appoints Renowned Industry Leader Amy Elkins as Chief Operating Officer

MIAMI, Sept. 8, 2025 /PRNewswire/ - eMed Population Health, Inc. today announced the appointment of Amy Elkins as Chief Operating Officer.

Investing.com
Aug 18th, 2025
Aon invests in eMed to expand GLP-1 weight management programs By Investing.com

Aon invests in eMed to expand GLP-1 weight management programs

PR Newswire
May 5th, 2025
Emed Announces Collaboration With Aon To Provide A Digital Glp-1 Benefit Program For Aon Colleagues

Partnership provides virtual clinical support with data driven measurement to improve adherence for obesity managementMIAMI, May 5, 2025 /PRNewswire/ -- eMed®, the leading Population Health technology platform in remote chronic care management and 24/7/365 live care, today announced an industry-changing collaboration with leading global professional services firm, Aon , to provide GLP-1 obesity management services for the company's U.S. employees.This collaboration builds off the momentum from Aon's recently released findings showing a seven percentage point reduction in the growth of medical spend in the second year of GLP-1 therapy, and a 44 percent reduction in risk of hospitalizations caused by major adverse cardiovascular events with adherent GLP-1 utilization. Both eMed and Aon are committed to improving population health by accessible, personalized, and effective healthcare solutions that support better health outcomes and address critical issues such as obesity, diabetes, and related comorbidities."We are thrilled to collaborate with Aon to bring our cutting-edge platform to their employees," said Dr. Patrice Harris, CEO of eMed. "Our platform is a science-based, all-in-one solution proven to deliver superior health outcomes for participants, while enabling employers to manage their spend on GLP-1s. Together with Aon, we're not just offering access to GLP-1s; we're ensuring they are used effectively to improve long-term employee health outcomes as demonstrated by Aon's groundbreaking analysis.""Our findings show that GLP-1s, when combined with holistic support like nutrition, exercise and mental health resources, can deliver lasting health improvements